Fellowship · Charleston, SC
Sponsored by Medical University of South Carolina College of Medicine
Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024.
MMWR. Morbidity and mortality weekly report · 2024 · 183 citations · Pedro Piedra
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.
The New England journal of medicine · 2021 · 409 citations · Susan Dorman
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice.
Nature communications · 2021 · 401 citations · Pedro Piedra
Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024.
JAMA pediatrics · 2025 · 64 citations · Pedro Piedra
Severe Monkeypox in Hospitalized Patients - United States, August 10-October 10, 2022.
MMWR. Morbidity and mortality weekly report · 2022 · 167 citations · Elliot Raizes
Wastewater sequencing reveals community and variant dynamics of the collective human virome.
Nature communications · 2023 · 92 citations · Pedro Piedra
Vulvovaginal Candidiasis: A Review of the Evidence for the 2021 Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022 · 99 citations · Gweneth Lazenby
Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 80 citations · Alexander Coltoff